Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3869067 | The Journal of Urology | 2011 | 6 Pages |
Abstract
Men with an undetectable prostate specific antigen for more than 10 years have a low risk of subsequent biochemical recurrence, with correspondingly lower rates of metastasis and death. These patients should be counseled that their risk of subsequent cancer related morbidity and mortality is low. Furthermore, these results suggest that annual prostate specific antigen testing may be safely discontinued after 10 years for men with a prostatectomy Gleason score 6 or less and/or limited life expectancy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Stacy Loeb, Zhaoyong Feng, Ashley Ross, Bruce J. Trock, Elizabeth B. Humphreys, Patrick C. Walsh,